TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - ABBOTT LABORATORIES Stock

Certificat

DE000SQ06P80

Delayed Deutsche Boerse AG 07:12:17 2024-06-06 EDT
0.88 EUR -8.33% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - ABBOTT LABORATORIES
Current month+17.07%
1 month-26.72%
Date Price Change
24-06-06 0.88 -8.33%
24-06-05 0.96 -2.04%
24-06-04 0.98 +3.16%
24-06-03 0.95 +15.85%
24-05-31 0.82 -3.53%

Delayed Quote Deutsche Boerse AG

Last update June 06, 2024 at 07:12 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Société Générale Société Générale
WKN SQ06P8
ISINDE000SQ06P80
Date issued 2022-09-29
Strike 92.91 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.87
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.02
Lowest since issue 0.27
Spread 0.08
Spread %8.51%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
103.2 USD
Average target price
125.4 USD
Spread / Average Target
+21.45%
Consensus